Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for diazoxide-sensitive diffuse hyperinsulinism.
7 publications have been identified in PubMed for diazoxide-sensitive diffuse hyperinsulinism. Research spans Epidemiology / Natural History (57%), Case Report / Case Series (29%), and Basic Science / Preclinical (14%).
Boodhansingh KE (2025). [PMID: 39382384](https://pubmed.ncbi.nlm.nih.gov/39382384/). *J Clin Endocrinol Metab*. [Basic Science / Preclinical]
Velde CD (2025). [PMID: 38963811](https://pubmed.ncbi.nlm.nih.gov/38963811/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Liberatore Junior RD (2025). [PMID: 40270719](https://pubmed.ncbi.nlm.nih.gov/40270719/). *Front Endocrinol (Lausanne)*. [Epidemiology / Natural History]
Pacheco G (2025). [PMID: 40828772](https://pubmed.ncbi.nlm.nih.gov/40828772/). *PLoS One*. [Epidemiology / Natural History]
Abdulghfar MM (2025). [PMID: 40652260](https://pubmed.ncbi.nlm.nih.gov/40652260/). *J Med Case Rep*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:10 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Butnariu LI (2024). [PMID: 38791571](https://pubmed.ncbi.nlm.nih.gov/38791571/). *Int J Mol Sci*. [Case Report / Case Series]
Cheng M (2024). [PMID: 40302972](https://pubmed.ncbi.nlm.nih.gov/40302972/). *Pediatr Diabetes*. [Epidemiology / Natural History]